OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer
Juan J. Alburquerque-Béjar, Pablo Navajas-Chocarro, Maria Saigí, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 4, pp. 101006-101006
Open Access | Times Cited: 14
Juan J. Alburquerque-Béjar, Pablo Navajas-Chocarro, Maria Saigí, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 4, pp. 101006-101006
Open Access | Times Cited: 14
Showing 14 citing articles:
Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
Qinyuan Gong, Rongzhen Xu
Frontiers in Immunology (2025) Vol. 15
Open Access
Qinyuan Gong, Rongzhen Xu
Frontiers in Immunology (2025) Vol. 15
Open Access
Therapeutic Applications of Programmed Death Ligand 1 Inhibitors in Small Cell Lung Cancer
Leena Nabipur, Michael Mouawad, Vishwanath Venketaraman
Biomedicines (2025) Vol. 13, Iss. 2, pp. 401-401
Open Access
Leena Nabipur, Michael Mouawad, Vishwanath Venketaraman
Biomedicines (2025) Vol. 13, Iss. 2, pp. 401-401
Open Access
Multi-omics analysis reveals the sensitivity of immunotherapy for unresectable non-small cell lung cancer
Rui Wu, K. Wei, Xingshuai Huang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Rui Wu, K. Wei, Xingshuai Huang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Potential role of lactylation in intrinsic immune pathways in lung cancer
Mengdie Huang, Ye Jin, Dandan Zhao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Mengdie Huang, Ye Jin, Dandan Zhao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer
Vinod Kumar, Zachary A. Yochum, Princey Devadassan, et al.
Oncogene (2024) Vol. 43, Iss. 19, pp. 1431-1444
Open Access | Times Cited: 4
Vinod Kumar, Zachary A. Yochum, Princey Devadassan, et al.
Oncogene (2024) Vol. 43, Iss. 19, pp. 1431-1444
Open Access | Times Cited: 4
CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancer
Kota Okuno, Kyonosuke Ikemura, Riku Okamoto, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0299827-e0299827
Open Access | Times Cited: 4
Kota Okuno, Kyonosuke Ikemura, Riku Okamoto, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0299827-e0299827
Open Access | Times Cited: 4
Biomarkers for Immune Checkpoint Inhibitors in Renal Cell Carcinoma
Spencer D. Martin, Ishmam Bhuiyan, Maryam Soleimani, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 4987-4987
Open Access | Times Cited: 9
Spencer D. Martin, Ishmam Bhuiyan, Maryam Soleimani, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 4987-4987
Open Access | Times Cited: 9
Deregulation of interferon-gamma receptor 1 expression and its implications for lung adenocarcinoma progression
Ángeles C. Tecalco-Cruz, Karen H Medina-Abreu, Enrique Oropeza-Martínez, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 2, pp. 195-207
Open Access | Times Cited: 3
Ángeles C. Tecalco-Cruz, Karen H Medina-Abreu, Enrique Oropeza-Martínez, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 2, pp. 195-207
Open Access | Times Cited: 3
New horizons in the mechanisms and therapeutic strategies for PD-L1 protein degradation in cancer
Zhi Li, Xi Yu, Zeting Yuan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189152-189152
Closed Access | Times Cited: 2
Zhi Li, Xi Yu, Zeting Yuan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189152-189152
Closed Access | Times Cited: 2
Advances in biomarkers for immunotherapy in small-cell lung cancer
Hui Li, Peiyan Zhao, Linwei Tian, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Hui Li, Peiyan Zhao, Linwei Tian, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Genomic and molecular alterations associated with primary resistance to immune checkpoint inhibitors
Jyoti Malhotra, Subhajyoti De, Kim B. Nguyen, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 1
Jyoti Malhotra, Subhajyoti De, Kim B. Nguyen, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 1
Astragaloside IV augments anti-PD-1 therapy to suppress tumor growth in lung cancer by remodeling the tumor microenvironment
Tao Wu, Shikui Wu, Hui Gao, et al.
European Journal of Histochemistry (2024) Vol. 68, Iss. 4
Open Access | Times Cited: 1
Tao Wu, Shikui Wu, Hui Gao, et al.
European Journal of Histochemistry (2024) Vol. 68, Iss. 4
Open Access | Times Cited: 1
Recent advances in immunotherapy for small cell lung cancer
Ziyuan Ren, Shijie Shang, Dawei Chen
Current Opinion in Oncology (2024)
Closed Access | Times Cited: 1
Ziyuan Ren, Shijie Shang, Dawei Chen
Current Opinion in Oncology (2024)
Closed Access | Times Cited: 1
Baicalein tethers CD274/PD-L1 for autophagic degradation to boost antitumor immunity
Bingjie Hao, Shumeng Lin, Haipeng Liu, et al.
Autophagy (2024), pp. 1-17
Closed Access
Bingjie Hao, Shumeng Lin, Haipeng Liu, et al.
Autophagy (2024), pp. 1-17
Closed Access
